First Quarter Conference CallQuick summary of important points:
1. ONC has 9 months cash as of March 31, 2024. This is a big concern. ONC claims to have sufficient funds to continue with TWO REGISTRATIONS TRIALS. This is false. They do NOT have enough cash to enter into any major trials at this time.
2. ONC has now admitted that the anticipated Breast Cancer "registrational enabling" trial that is forever being kicked further into the future will now be a trial that is effiecient, flexible and might lead to approval. But they also said that it could lead to a phase 3. Seriously. Listen to the call. It appears now that the reason they dropped the "Phase 3" and now call it "Registrational Enabling" is because they are hoping and praying for a homerun with a smaller patient set. Clearly, they DO NOT have funds and they DO NOT have a partner lined up for Breast Cancer.
3. The most promising news, strangly, is that ONC says the will "provide and update" on the registraional trial for Panc in H1, 2024. That gives them less than 7 weeks to provide the promised update. They could have done it today, of course, except (and here's the hope) MAYBE they are close to announcing a partnership for this trial and they are within 7 weeks of getting it all signed off and such. Let's hope so, becuase there is NO HOPE for ONC ever getting anywhere near a phase 3 in Breast Cancer.